COPE Healthcare Consulting, Inc. announced that it has entered into a stock purchase agreement with Mindtree Limited to receive $4,500,000 in an equity round of funding on April 4, 2022. The company will issue series A preferred stock in the transaction, which are convertible into common shares, representing 6.64% stake in the company. As a part of the transaction, the investor will join the board of the company. The transaction is expected to close on or before May 4, 2022.